To further investigate the potential of T. gondii ME49Δompdc/gra4 induced CD64+MAR‐1+CD11b+ DCs in anti‐tumor activity, we established an in vivo adoptive transfer model. This evidence concerns the gene FCGR1A and neoplasm.